Sensus Healthcare, Inc. (SRTS) News

Sensus Healthcare, Inc. (SRTS): $3.41

0.08 (+2.40%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Filter SRTS News Items

SRTS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest SRTS News From Around the Web

Below are the latest news stories about SENSUS HEALTHCARE INC that investors may wish to consider to help them evaluate SRTS as an investment opportunity.

Q3 2023 Sensus Healthcare Inc Earnings Call

Q3 2023 Sensus Healthcare Inc Earnings Call

Yahoo | November 10, 2023

Sensus Healthcare Reports Third Quarter 2023 Financial Results

Revenues of $3.9 million reflect seasonality and macroeconomic conditions Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and nine months ended September 30, 2023. Highlights from the third

Yahoo | November 9, 2023

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

BOCA RATON, Fla, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 9, 2023 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2023. In addition, management will provide a business update and a discussion on recent and upcoming mile

Yahoo | November 2, 2023

Sensus Healthcare (NASDAQ:SRTS) Shareholders Will Want The ROCE Trajectory To Continue

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Yahoo | October 13, 2023

Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

BOCA RATON, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will deliver a company presentation and hold investor meetings at the Roth MKM 2023 Healthcare Opportunities Conference being held October 12, 2023 in New York City. Sensus management will also participate in the

Yahoo | October 9, 2023

7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio

Dive into these seven strong buy biotech stocks, handpicked by Wall Street, to inject vigor into your investment game.

Josh Enomoto on InvestorPlace | September 28, 2023

Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital

Continues SRT-100+™ customer expansion to hospital oncology departments for the outpatient treatment of non-melanoma skin cancersBOCA RATON, Fla. , Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the shipment of an SRT-100+™ System to Cape Cod Hospital in Hyannis, Massachusetts, the second SR

Yahoo | September 28, 2023

Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego

BOCA RATON, Fla, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces its participation in the American Society for Radiation Oncology (ASTRO) Annual Meeting to be held in San Diego from October 1-4. Leveraging this esteemed event, Sensus Healthcare is set to present its full line of state-of-the-

Yahoo | September 26, 2023

Positive Signs As Multiple Insiders Buy Sensus Healthcare Stock

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

Yahoo | September 23, 2023

Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Stock Is Going Strong: Have Financials A Role To Play?

Sensus Healthcare's (NASDAQ:SRTS) stock is up by a considerable 16% over the past three months. As most would know...

Yahoo | September 2, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!